Lung Denervation Trial targets Novel COPD Phenotype

First Patient Treated in the AIRFLOW-4 trial MINNEAPOLIS, July 1, 2026 /PRNewswire/ -- Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases has announced the first patient treated in its pivotal randomized trial of dNerva® targeted lung denervation...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.